Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Feb;29(1):47-52.
doi: 10.1007/s00292-007-0953-3.

[Hepatocellular carcinoma in the non-cirrhotic liver]

[Article in German]
Affiliations
Review

[Hepatocellular carcinoma in the non-cirrhotic liver]

[Article in German]
M Evert et al. Pathologe. 2008 Feb.

Abstract

Of hepatocellular carcinomas (HCC), 15-20% occur in the non-cirrhotic liver. All factors which cause HCC when liver cirrhosis (LC) is present, can also lead to HCC without LC. On the basis of the relative frequency, HCC can be roughly differentiated into 3 groups: 1) HCC, rarely occurring without cirrhosis (e.g. virus hepatitis, alcohol abuse). 2) HCC, frequently occurring without LC (alpha1-antitrypsin deficiency, hemochromatosis, non-alcoholic fatty liver disease). 3) HCC, consistently occurring without LC (glycogen storage disease type 1, consumption of oral contraceptives/anabolic steroids). In groups 1 and 2 the level of hepatocellular toxicity necessary to reach LC is not yet achieved but the carcinogenic effect is already strong enough to induce HCC, possibly owing to the influence of additional carcinogens or host factors. In group 3, the carcinogenic effect is mediated by a long-standing alteration of the hepatocellular metabolism that is of low toxic effect and does not lead to cell death, but is nevertheless carcinogenic. In these cases, the initial formation of hepatocellular adenomas that subsequently transform into HCC is a common finding (adenoma-carcinoma sequence).

PubMed Disclaimer

References

    1. Cancer. 1995 May 1;75(9):2220-32 - PubMed
    1. Lab Invest. 2005 Jan;85(1):99-108 - PubMed
    1. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;50(4):321-37 - PubMed
    1. Dig Dis Sci. 2006 May;51(5):952-5 - PubMed
    1. Am J Clin Pathol. 1996 Jan;105(1):65-75 - PubMed

MeSH terms

LinkOut - more resources